A Probiotic Nutritional Supplement Improves Glycemic Control and Biomarkers of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus
The results observed with BeaT-2 were comprehensively indicative for improvements in the cardiometabolic situation. BeaT-2 may be a valuable supplement to any existing treatment combination in patients with type 2 diabetes.
Authors
- Pamela Canaviri-Paz (ORCID: https://orcid.org/0000-0002-6639-2997)
- Daiva Kalasauske
- Mina R. Hanna
- Daniela Sachsenheimer
- Julia Jantz
- Johan de Faire
- Andreas Pfützner
Institutions
- University of Luxembourg (LU)
- Department of Medical Sciences (RU)
Publication Details
- Journal
- Nutrition and Metabolic Insights
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1177/11786388251413658
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00